目的:研究山豆根(Sophora tonkinensis Gagnep)治疗哮喘的物质基础和作用机制。方法:首先对山豆根进行液相色谱–质谱联用分析,获得山豆根的化学成分,随后通过数据库TCMIP,获得山豆根成分所能预测的靶点。在CTD数据库中,查找出与哮喘相关靶点,通过韦恩图对山豆根化学成分的靶点与其哮喘相关靶点进行结合,得出二者相互交叉的部分,即为交集靶点。采用Cytoscape v3.8.0软件构建“成分–靶点–疾病”的网络关系,采用DAVID数据库对交集靶点进行KEGG通路分析。最后对交集靶点进一步分析,获得山豆根治疗哮喘的核心靶点。结果:获得127个交集靶点与12个山豆根治疗哮喘的活性成分,筛选出31条KEGG信号通路,进一步挑选出核心靶点7个。结论:本文对山豆根具有多成分、多靶点、多通路等特点的哮喘治疗方法进行了研究和分析,为今后哮喘的治疗提供了理论依据。
Objective: To study the material basis and mechanism of Sophora tonkinensis Gagnep in the treat-ment of asthma. Methods: Firstly, the chemical constituents of Sophora tonkinensis Gagnep were analyzed by liquid chromatography-mass spectrometry, and then the predicted targets of Sophora tonkinensis Gagnep were obtained by TCMIP database. In the CTD database, find out the asthma related targets, combine the targets of chemical components of Sophora tonkinensis Gagnep and its asthma related targets through Wayne diagram, and get the intersection part of the two. Those were the intersection targets. Cytoscape v3.8.0 software was used to construct the network relationship of “component-target-disease”, and DAVID database was used to analyze the KEGG pathway of the intersection targets. Finally, the intersection targets were further analyzed to obtain the core target of Sophora tonkinensis Gagnep in the treatment of asthma. Results: One hundred and twenty-seven intersecting targets and twelve active components of Sophora tonkinensis Gagnep were obtained, thirty-one KEGG signal pathways were screened, and seven core targets were further selected. Conclusion: This paper studied and analyzed the treatment of asthma with the characteris-tics of multi-components, multi-targets and multi-pathways, which provided a theoretical basis for the future treatment of asthma.
生物化学网络,山豆根,哮喘,物质基础,作用机制,靶点, Biochemical Network Sophora Tonkinensis Gagnep Asthma Material Basis Mechanism of Action Target摘要
Guizhou University of Traditional Chinese Medicine, Guiyang Guizhou
Received: Jul. 15th, 2022; accepted: Aug. 9th, 2022; published: Aug. 15th, 2022
ABSTRACT
Objective: To study the material basis and mechanism of Sophora tonkinensis Gagnep in the treatment of asthma. Methods: Firstly, the chemical constituents of Sophora tonkinensis Gagnep were analyzed by liquid chromatography-mass spectrometry, and then the predicted targets of Sophora tonkinensis Gagnep were obtained by TCMIP database. In the CTD database, find out the asthma related targets, combine the targets of chemical components of Sophora tonkinensis Gagnep and its asthma related targets through Wayne diagram, and get the intersection part of the two. Those were the intersection targets. Cytoscape v3.8.0 software was used to construct the network relationship of “component-target-disease”, and DAVID database was used to analyze the KEGG pathway of the intersection targets. Finally, the intersection targets were further analyzed to obtain the core target of Sophora tonkinensis Gagnep in the treatment of asthma. Results: One hundred and twenty-seven intersecting targets and twelve active components of Sophora tonkinensis Gagnep were obtained, thirty-one KEGG signal pathways were screened, and seven core targets were further selected. Conclusion: This paper studied and analyzed the treatment of asthma with the characteristics of multi-components, multi-targets and multi-pathways, which provided a theoretical basis for the future treatment of asthma.
Keywords:Biochemical Network, Sophora tonkinensis Gagnep, Asthma, Material Basis, Mechanism of Action, Target
何雅风,李红美,魏明星,唐文雅,张帅男,李煦照. 基于生物化学网络探讨山豆根干预哮喘的作用机制及物质基础Study on the Mechanism and Material Basis of Sophora tonkinensis Gagnep on Asthma Based on Biochemical Network[J]. 药物化学, 2022, 10(03): 265-274. https://doi.org/10.12677/HJMCe.2022.103027
参考文献References王晶波, 熊丽琼. 中医药治疗哮喘的研究概述[J]. 辽宁中医杂志, 2022, 49(4): 218-220.侯新, 赵文娟. 从五脏论治哮喘的发病和作用机制[J]. 中国药物经济学, 2022, 17(1): 125-128.丁佩兰. 山豆根和苦参化学成分的比较研究[D]: [博士学位论文]. 上海: 复旦大学, 2004.孟丽萍. 基于古今药方纵横的山豆根应用规律研究[D]: [硕士学位论文]. 济南: 山东中医药大学, 2013.Yoo, H., Kang, M., Pyo, S., et al. (2017) SKI3301, a Purified Herbal Extract from Sophora tonkinensis, Inhibited Airway Inflammation and Bronchospasm in Allergic Asthma Animal Models in Vivo. Journal of Ethnopharmacology, 206, 298-305. <br>https://doi.org/10.1016/j.jep.2017.05.012余丹, 迟骁玮. 基于生物信息学技术探讨补骨脂致肝损伤的作用机制[J]. 药学实践杂志, 2022, 40(3): 254-258.刘嫣然, 施春英, 李玲. 基于生物信息学探讨芍药甘草汤作用机制[J]. 青岛大学学报(自然科学版), 2021, 34(3): 63-70.Dahgam, S., Nyberg, F., Modig, L., et al. (2012) Single Nucleotide Polymorphisms in the NOS2 and NOS3 Genes Are Associated with Exhaled Nitric Oxide. Journal of Medical Genetics, 49, 200-205.
<br>https://doi.org/10.1136/jmedgenet-2011-100584Storm van’s, G.K., Wechsler, M., Grasemann, H., et al. (2003) Association of a Missense Mutation in the NOS3 Gene with Exhaled Nitric Oxide Levels. American Journal of Respiratory and Critical Care Medicine, 168, 228-231.
<br>https://doi.org/10.1164/rccm.200212-1491BCWu, M., Yang, J., Liu, T., et al. (2022) Effect of SRC Tyrosine Kinase on a Rat Model of Asthma. Experimental and Therapeutic Medicine, 23, 172. <br>https://doi.org/10.3892/etm.2021.11095Wang, L., Xu, J., Liu, H., et al. (2019) PM2.5 Inhibits SOD1 Ex-pression by Up-Regulating microRNA-206 and Promotes ROS Accumulation and Disease Progression in Asthmatic Mice. International Immunopharmacology, 76, Article ID: 105871. <br>https://doi.org/10.1016/j.intimp.2019.105871Qu, J., Li, Y., Zhong, W., et al. (2017) Recent Developments in the Role of Reactive Oxygen Species in Allergic Asthma. Journal of Thoracic Disease, 9, E32-E43. <br>https://doi.org/10.21037/jtd.2017.01.05Molenaar, R.J., Maciejewski, J.P., Wilmink, J.W., et al. (2018) Wild-Type and Mutated IDH1/2 Enzymes and Therapy Responses. Oncogene, 37, 1949-1960. <br>https://doi.org/10.1038/s41388-017-0077-zChan, I.H., Tang, N.L., Leung, T.F., et al. (2007) Association of Prostaglandin-Endoperoxide Synthase 2 Gene Polymorphisms with Asthma and Atopy in Chinese Children. Allergy, 62, 802-809.
<br>https://doi.org/10.1111/j.1398-9995.2007.01400.xTaha, R., Olivenstein, R., Utsumi, T., et al. (2000) Prosta-glandin H Synthase 2 Expression in Airway Cells from Patients with Asthma and Chronic Obstructive Pulmonary Dis-ease. American Journal of Respiratory and Critical Care Medicine, 161, 636-640. <br>https://doi.org/10.1164/ajrccm.161.2.9811063李英, 罗银河, 王孟清, 等. 咳喘宁对病毒诱发哮喘模型大鼠CD4+、CD8+ T细胞内信号转导子和转录激活子6表达的影响[J]. 中国中医药信息杂志, 2013, 20(10): 25-28.Zheng, Y., Zhang, R., Shi, W., Li, L., Liu, H., et al. (2020) Metabolism and Pharmacological Activities of the Natural Health-Benefiting Compound Diosmin. Food & Function, 11, 8472-8492. <br>https://doi.org/10.1039/D0FO01598A程安琪, 佟训靓, 王辰. 吸烟与支气管哮喘研究进展[J]. 中华临床免疫和变态反应杂志, 2019, 13(1): 60-66.Petruczynik, A., Wróblewski, K., Misiurek, J., et al. (2020) Determi-nation of Cytisine and N-Methylcytisine from Selected Plant Extracts by High-Performance Liquid Chromatography and Comparison of Their Cytotoxic Activity. Toxins (Basel), 12, 557. <br>https://doi.org/10.3390/toxins12090557Tzankova, V. and Danchev, N. (2014) Cytisine—From Ethomedical Use to the Development as a Natural Alternative for Smoking Cessation. Biotechnology & Biotechnological Equipment, 21, 151-160.
<br>https://doi.org/10.1080/13102818.2007.10817436雷永红. 支气管哮喘发病机制中细胞因子作用的研究[J]. 九江学院学报(自然科学版), 2013, 28(1): 72-74.齐玲, 王玮瑶, 张艳春, 等. 肿瘤坏死因子α信号传导通路在儿童哮喘发病机制中的作用[J]. 吉林大学学报(医学版), 2015, 41(2): 379-382.邓同乐, 吕光荣, 管建红. 一氧化氮在哮喘发病机制中的作用及治疗应用[J]. 云南中医学院学报, 2001(2): 28-31.Jiao, H.Y., Su, W.W., Li, P.B., Liao, Y., et al. (2015) Therapeutic Effects of Naringin in a Guinea Pig Model of Ovalbumin-Induced Cough-Variant Asthma. Pulmonary Pharmacology & Therapeutics, 33, 59-65.
<br>https://doi.org/10.1016/j.pupt.2015.07.002Maarsingh, H., Zaagsma, J. and Meurs, H. (2008) Arginine Ho-meostasis in Allergic Asthma. European Journal of Pharmacology, 585, 375-384. <br>https://doi.org/10.1016/j.ejphar.2008.02.096Kochański, L., Kossmann, S., Rogala, E., et al. (1980) Sputum Arginase Activity in Bronchial Asthma. Pneumonologia i Alergologia Polska, 48, 329-332.Bonser, L.R. and Erle, D.J. (2017) Airway Mucus and Asthma: The Role of MUC5AC and MUC5B. Journal of Clinical Medicine, 6, 112. <br>https://doi.org/10.3390/jcm6120112Montuschi, P. and Peters-Golden, M.L. (2010) Leukotriene Modifiers for Asthma Treatment. Clinical & Experimental Allergy, 40, 1732-1741. <br>https://doi.org/10.1111/j.1365-2222.2010.03630.xBao, Z.S., Hong, L., Guan, Y., et al. (2011) Inhibition of Airway Inflammation, Hyperresponsiveness and Remodeling by Soy Isoflavone in a Murine Model of Allergic Asthma. International Immunopharmacology, 11, 899-906.
<br>https://doi.org/10.1016/j.intimp.2011.02.001Lago, J.H., Toledo-Arruda, A.C., Mernak, M., et al. (2014) Structure-Activity Association of Flavonoids in Lung Diseases. Molecules, 19, 3570-3595. <br>https://doi.org/10.3390/molecules19033570Possa, S.S., Leick, E.A., Prado, C.M., et al. (2013) Eosinophilic Inflammation in Allergic Asthma. Frontiers in Pharmacology, 4, Article No. 46. <br>https://doi.org/10.3389/fphar.2013.00046Lee, H.E., Jeon, S.J., Ryu, B., et al. (2016) Swertisin, a C-glucosylflavone, Ameliorates Scopolamine-Induced Memory Impairment in Mice with Its Adenosine A1 Receptor Antagonistic Property. Behavioural Brain Research, 306, 137-145.
<br>https://doi.org/10.1016/j.bbr.2016.03.030Fred, E.M. and Eugene, S. (1942) Treatment of Asthmatic Parox-ysm with Nicotinic Acid. Allergy, 13, 397-403.
<br>https://doi.org/10.1016/S0021-8707(42)90298-3